[
    [
        {
            "time": "2018-03-15",
            "original_text": "Teva Stock Rises on Patent Settlement With Neos Therapeutics",
            "features": {
                "keywords": [
                    "Teva",
                    "Patent Settlement",
                    "Neos Therapeutics"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Teva Stock Rises on Patent Settlement With Neos Therapeutics",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-12-20",
            "original_text": "Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019",
            "features": {
                "keywords": [
                    "J&J",
                    "Drug Stocks",
                    "Buy Recommendation"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 9,
                "Source_Recency": 2
            }
        },
        {
            "time": "2019-02-22",
            "original_text": "Innovent, Lilly Co-developed Tyvyt Gets China's NMPA Approval For CHL",
            "features": {
                "keywords": [
                    "Innovent",
                    "Lilly",
                    "Tyvyt",
                    "NMPA Approval",
                    "CHL"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Innovent, Lilly Co-developed Tyvyt Gets China's NMPA Approval For CHL",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]